{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:36:19Z","timestamp":1793957779219,"version":"4.8.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1225725N"],"award-info":[{"award-number":["1225725N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G065721N"],"award-info":[{"award-number":["G065721N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["PDMT2\/21\/069"],"award-info":[{"award-number":["PDMT2\/21\/069"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-24-1300693"],"award-info":[{"award-number":["AARF-24-1300693"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["22-AAIIA-963171"],"award-info":[{"award-number":["22-AAIIA-963171"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2022019F"],"award-info":[{"award-number":["A2022019F"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU Joint moodmarker","award":["01ED1202A"],"award-info":[{"award-number":["01ED1202A"]}]},{"name":"PreFrontAls","award":["01ED1512"],"award-info":[{"award-number":["01ED1512"]}]},{"name":"German Federal Ministry of Education and Research","award":["FTLDc 01GI1007A"],"award-info":[{"award-number":["FTLDc 01GI1007A"]}]},{"name":"Foundation of the State Baden-Wu\u0308rttemberg","award":["D.3830"],"award-info":[{"award-number":["D.3830"]}]},{"name":"Boehringer Ingelheim Ulm University BioCenter","award":["D.5009"],"award-info":[{"award-number":["D.5009"]}]},{"name":"Thierry Latran Foundation"},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010570","name":"Nieders\u00e4chsisches Ministerium f\u00fcr Wissenschaft und Kultur","doi-asserted-by":"publisher","award":["ZN3553"],"award-info":[{"award-number":["ZN3553"]}],"id":[{"id":"10.13039\/501100010570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001646","name":"Robert-Bosch-Stiftung","doi-asserted-by":"crossref","award":["32.5.1140.0007.O\/MA01"],"award-info":[{"award-number":["32.5.1140.0007.O\/MA01"]}],"id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mady Browaeys Fund for Research into Frontotemporal Degeneration"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS118584"],"award-info":[{"award-number":["R01 NS118584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["C14\/17\/107"],"award-info":[{"award-number":["C14\/17\/107"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TH-624-4-1, 4-2, 6-1"],"award-info":[{"award-number":["TH-624-4-1, 4-2, 6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["10810"],"award-info":[{"award-number":["10810"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02929-9","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:22:23Z","timestamp":1757910143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Differences and overlaps in TDP-43 pathology of \u2018pure\u2019 LATE-NC compared to LATE-NC coexisting with Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"150","author":[{"given":"Sandra O.","family":"Tom\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Gawor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ospitalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Ronisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A. F.","family":"von Arnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estifanos","family":"Ghebremedhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Laureyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Sleegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar Rudolf","family":"Thal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2929_CR1","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association workgroup. Alzheimers Dement 20:5143\u20135169.  https:\/\/doi.org\/10.1002\/alz.13859","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2929_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142:1503\u20131527. https:\/\/doi.org\/10.1093\/brain\/awz099","journal-title":"Brain"},{"issue":"2","key":"2929_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.26711","volume":"94","author":"PT Nelson","year":"2023","unstructured":"Nelson PT, Schneider JA, Jicha GA, Duong MT, Wolk DA (2023) When Alzheimer\u2019s is late: why does it matter? Ann Neurol 94:211\u2013222. https:\/\/doi.org\/10.1002\/ana.26711","journal-title":"Ann Neurol"},{"key":"2929_CR4","doi-asserted-by":"publisher","unstructured":"Kapasi A, Yu L, Boyle PA, Barnes LL, Bennett DA, Schneider JA (2020) Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology 95:e1951. https:\/\/doi.org\/10.1212\/WNL.0000000000010454","DOI":"10.1212\/WNL.0000000000010454"},{"key":"2929_CR5","doi-asserted-by":"publisher","unstructured":"Wolk DA, Boyle PA, Nelson PT, Apostolova L, Arfanakis K, Carlsson CM et al (2025) Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy. Alzheimer Dement\u00a021:e14202.\u00a0https:\/\/doi.org\/10.1002\/alz.14202","DOI":"10.1002\/alz.14202"},{"issue":"4","key":"2929_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/WAD.0000000000000334","volume":"33","author":"A Kapasi","year":"2019","unstructured":"Kapasi A, Yu L, Stewart CC, Schneider JA, Bennett DA, Boyle PA (2019) Association of TDP-43 pathology with domain-specific literacy in older persons. Alzheimer Dis Assoc Disord 33:315\u2013320.\u00a0https:\/\/doi.org\/10.1097\/WAD.0000000000000334","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2929_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/alz.12763","volume":"19","author":"MJ Grothe","year":"2023","unstructured":"Grothe MJ, Moscoso A, Silva-Rodr\u00edguez J, Lange C, Nho K, Saykin AJ et al (2023) Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC. Alzheimers Dement 19:1234\u20131244. https:\/\/doi.org\/10.1002\/alz.12763","journal-title":"Alzheimers Dement"},{"key":"2929_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/alz.14500","volume":"21","author":"S Agrawal","year":"2025","unstructured":"Agrawal S, Yu L, Leurgans SE, Nag S, Barnes LL, Bennett DA et al (2025) Hippocampal neuronal loss and cognitive decline in LATE-NC and ADNC among community-dwelling older persons. Alzheimers Dement 21:e14500. https:\/\/doi.org\/10.1002\/alz.14500","journal-title":"Alzheimers Dement"},{"key":"2929_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70483","author":"K Gawor","year":"2025","unstructured":"Gawor K, Verrept S, Arekatla G, Wouters D, Ronisz A, Hecht M et al (2025) Alzheimer\u2019s disease and its co-pathologies: implications for hippocampal degeneration, cognitive decline, and the role of APOE \u03b54. Alzheimer Dement\u00a021:e70483.\u00a0https:\/\/doi.org\/10.1002\/alz.70483","journal-title":"Alzheimer Dement"},{"issue":"5","key":"2929_CR10","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1002\/alz.13780","volume":"20","author":"A Kapasi","year":"2024","unstructured":"Kapasi A, Boyle PA, Yu L, Leurgans SE, Agrawal S, Bennett DA et al (2024) Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults. Alzheimers Dement 20:3193\u20133202.\u00a0https:\/\/doi.org\/10.1002\/alz.13780","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2929_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/jnen\/nlae113","volume":"84","author":"PT Nelson","year":"2025","unstructured":"Nelson PT (2025) New criteria to predict LATE-NC in the clinical setting: probable\/possible LATE and LANS. J Neuropathol Exp Neurol 84:2\u20137. https:\/\/doi.org\/10.1093\/jnen\/nlae113","journal-title":"J Neuropathol Exp Neurol"},{"key":"2929_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/jnen\/nlab050","volume":"80","author":"PT Nelson","year":"2021","unstructured":"Nelson PT (2021) LATE neuropathologic changes with little or no Alzheimer disease is common and is associated with cognitive impairment but not frontotemporal dementia. J Neuropathol Exp Neurol 80:649\u2013651. https:\/\/doi.org\/10.1093\/jnen\/nlab050","journal-title":"J Neuropathol Exp Neurol"},{"key":"2929_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","volume":"144","author":"PT Nelson","year":"2022","unstructured":"Nelson PT, Brayne C, Flanagan ME, Abner EL, Agrawal S, Attems J et al (2022) Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol 144:27\u201344. https:\/\/doi.org\/10.1007\/s00401-022-02444-1","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2929_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-2009-1227","volume":"18","author":"JA Schneider","year":"2009","unstructured":"Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA (2009) The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis 18:691\u2013701. https:\/\/doi.org\/10.3233\/JAD-2009-1227","journal-title":"J Alzheimers Dis"},{"key":"2929_CR15","doi-asserted-by":"publisher","unstructured":"Tom\u00e9 SO, Gawor K, Thal DR (2023) LATE-NC in Alzheimer\u2019s disease: molecular aspects and synergies. Brain Pathol\u00a034:e13213.\u00a0https:\/\/doi.org\/10.1111\/bpa.13213","DOI":"10.1111\/bpa.13213"},{"key":"2929_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-014-1269-z.TDP-43","volume":"127","author":"KA Josephs","year":"2015","unstructured":"Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM et al (2015) TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease. Acta Neuropathol 127:811\u2013824. https:\/\/doi.org\/10.1007\/s00401-014-1269-z.TDP-43","journal-title":"Acta Neuropathol"},{"key":"2929_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/brain\/aww341","volume":"140","author":"PA Boyle","year":"2017","unstructured":"Boyle PA, Yang J, Yu L, Leurgans SE, Capuano AW, Schneider JA et al (2017) Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain 140:804\u2013812. https:\/\/doi.org\/10.1093\/brain\/aww341","journal-title":"Brain"},{"key":"2929_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/jnen\/nlw014","volume":"75","author":"MD Cykowski","year":"2016","unstructured":"Cykowski MD, Takei H, Van Eldik LJ, Schmitt FA, Jicha GA, Powell SZ et al (2016) Hippocampal sclerosis but not normal aging or Alzheimer disease is associated with TDP-43 pathology in the basal forebrain of aged persons. J Neuropathol Exp Neurol 75:397\u2013407. https:\/\/doi.org\/10.1093\/jnen\/nlw014","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2929_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40478-019-0743-1","volume":"7","author":"CS Latimer","year":"2019","unstructured":"Latimer CS, Burke BT, Liachko NF, Currey HN, Kilgore MD, Gibbons LE et al (2019) Resistance and resilience to Alzheimer\u2019s disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort. Acta Neuropathol Commun 7:9. https:\/\/doi.org\/10.1186\/s40478-019-0743-1","journal-title":"Acta Neuropathol Commun"},{"key":"2929_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/ana.26762","volume":"94","author":"G Minogue","year":"2023","unstructured":"Minogue G, Kawles A, Zouridakis A, Keszycki R, Macomber A, Lubbat V et al (2023) Distinct patterns of hippocampal pathology in Alzheimer\u2019s disease with transactive response DNA-binding protein 43. Ann Neurol 94:1036\u20131047. https:\/\/doi.org\/10.1002\/ana.26762","journal-title":"Ann Neurol"},{"key":"2929_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/J.JALZ.2012.10.013","volume":"9","author":"E Rubino","year":"2013","unstructured":"Rubino E, Vacca A, Govone F, De Martino P, Pinessi L, Rainero I (2013) Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: a meta-analysis. Alzheimers Dement 9:706\u2013713. https:\/\/doi.org\/10.1016\/J.JALZ.2012.10.013","journal-title":"Alzheimers Dement"},{"key":"2929_CR22","doi-asserted-by":"publisher","unstructured":"Thal DR, Del Tredici K, Ludolph AC, Hoozemans JJ, Rozemuller AJ, Braak H, Knippschild U (2011) Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response. Acta Neuropathol 122:577\u2013589. https:\/\/doi.org\/10.1007\/s00401-011-0871-6","DOI":"10.1007\/s00401-011-0871-6"},{"key":"2929_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1750-3639.2008.00244.x","volume":"20","author":"PT Nelson","year":"2010","unstructured":"Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD et al (2010) Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol 20:66\u201379. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00244.x","journal-title":"Brain Pathol"},{"key":"2929_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/bpa.12505","volume":"28","author":"VD Smith","year":"2018","unstructured":"Smith VD, Bachstetter AD, Ighodaro E, Roberts K, Abner EL, Fardo DW et al (2018) Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi. Brain Pathol 28:264\u2013273. https:\/\/doi.org\/10.1111\/bpa.12505","journal-title":"Brain Pathol"},{"key":"2929_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00401-024-02821-y","volume":"148","author":"Y Katsumata","year":"2024","unstructured":"Katsumata Y, Wu X, Aung KZ, Fardo DW, Woodworth DC, Sajjadi SA et al (2024) Pure LATE-NC: frequency, clinical impact, and the importance of considering APOE genotype when assessing this and other subtypes of non-Alzheimer\u2019s pathologies. Acta Neuropathol 148:66.  https:\/\/doi.org\/10.1007\/s00401-024-02821-y","journal-title":"Acta Neuropathol"},{"key":"2929_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","volume":"126","author":"GG Kovacs","year":"2013","unstructured":"Kovacs GG, Milenkovic I, W\u00f6hrer A, H\u00f6ftberger R, Gelpi E, Haberler C et al (2013) Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 126:365\u2013384. https:\/\/doi.org\/10.1007\/s00401-013-1157-y","journal-title":"Acta Neuropathol"},{"key":"2929_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-018-1872-5","volume":"136","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Corrada MM, Kovacs GG, Dominique M, Caswell C, Xie SX et al (2018) Non-Alzheimer\u2019s contributions to dementia and cognitive resilience in the 90+ study. Acta Neuropathol 136:377\u2013388. https:\/\/doi.org\/10.1007\/s00401-018-1872-5","journal-title":"Acta Neuropathol"},{"key":"2929_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","volume":"134","author":"EB Lee","year":"2017","unstructured":"Lee EB, Porta S, Baer MG, Xu Y, Suh E, Kwong LK et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65\u201378. https:\/\/doi.org\/10.1007\/s00401-017-1679-9","journal-title":"Acta Neuropathol"},{"key":"2929_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IRA Mackenzie","year":"2011","unstructured":"Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111\u2013113. https:\/\/doi.org\/10.1007\/s00401-011-0845-8","journal-title":"Acta Neuropathol"},{"key":"2929_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-022-02416-5","volume":"143","author":"MD Cykowski","year":"2022","unstructured":"Cykowski MD, Arumanayagam AS, Powell SZ, Rivera AL, Abner EL, Roman GC et al (2022) Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies. Acta Neuropathol 143:531\u2013545. https:\/\/doi.org\/10.1007\/s00401-022-02416-5","journal-title":"Acta Neuropathol"},{"key":"2929_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00401-018-1951-7","volume":"137","author":"KA Josephs","year":"2019","unstructured":"Josephs KA, Murray ME, Tosakulwong N, Weigand SD, Serie AM, Ralph PB et al (2019) Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains. Acta Neuropathol 137:227\u2013238. https:\/\/doi.org\/10.1007\/s00401-018-1951-7","journal-title":"Acta Neuropathol"},{"key":"2929_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s007020050096","volume":"105","author":"H Braak","year":"1998","unstructured":"Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105:801\u2013819. https:\/\/doi.org\/10.1007\/s007020050096","journal-title":"J Neural Transm"},{"key":"2929_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. https:\/\/doi.org\/10.1007\/s00401-014-1349-0","journal-title":"Acta Neuropathol"},{"key":"2929_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/S00401-015-1509-X","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87\u2013102. https:\/\/doi.org\/10.1007\/S00401-015-1509-X","journal-title":"Acta Neuropathol"},{"key":"2929_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"2929_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-022-02524-2","volume":"145","author":"PT Nelson","year":"2023","unstructured":"Nelson PT, Lee EB, Cykowski MD, Alafuzoff I, Arfanakis K, Attems J et al (2023) Late-NC staging in routine neuropathologic diagnosis\u202f: an update. Acta Neuropathol 145:159\u2013173. https:\/\/doi.org\/10.1007\/s00401-022-02524-2","journal-title":"Acta Neuropathol"},{"key":"2929_CR37","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-A","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412\u20132414. https:\/\/doi.org\/10.1212\/WNL.43.11.2412-A","journal-title":"Neurology"},{"key":"2929_CR38","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2174\/156720512801322591","volume":"9","author":"FA Schmitt","year":"2013","unstructured":"Schmitt FA, Nelson P, Abner E, Scheff S, Jicha G, Smith C et al (2013) University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res 9:724\u2013733. https:\/\/doi.org\/10.2174\/156720512801322591","journal-title":"Curr Alzheimer Res"},{"key":"2929_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40478-016-0399-z","volume":"4","author":"MD Ikonomovic","year":"2016","unstructured":"Ikonomovic MD, Buckley CJ, Heurling K, Sherwin P, Jones PA, Zanette M et al (2016) Post-mortem histopathology underlying \u03b2-amyloid PET imaging following flutemetamol F 18 injection. Acta Neuropathol Commun 4:130. https:\/\/doi.org\/10.1186\/s40478-016-0399-z","journal-title":"Acta Neuropathol Commun"},{"key":"2929_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"key":"2929_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2929_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"2929_CR43","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/WNL.58.12.1791","journal-title":"Neurology"},{"key":"2929_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-024-02815-w","volume":"148","author":"C Laureyssen","year":"2024","unstructured":"Laureyssen C, K\u00fc\u00e7\u00fckali F, Van Dongen J, Gawor K, Tom\u00e9 SO, Ronisz A et al (2024) Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer\u2019s-type dementia. Acta Neuropathol 148:55. https:\/\/doi.org\/10.1007\/s00401-024-02815-w","journal-title":"Acta Neuropathol"},{"key":"2929_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3121","volume":"13","author":"EB Lee","year":"2012","unstructured":"Lee EB, Lee M-Y, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13:38\u201350. https:\/\/doi.org\/10.1038\/nrn3121","journal-title":"Nat Rev Neurosci"},{"key":"2929_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40478-020-00934-5","volume":"8","author":"SO Tom\u00e9","year":"2020","unstructured":"Tom\u00e9 SO, Vandenberghe R, Ospitalieri S, Van Schoor E, Tousseyn T, Otto M et al (2020) Distinct molecular patterns of TDP-43 pathology in Alzheimer\u2019s disease: relationship with clinical phenotypes. Acta Neuropathol Commun 8:61. https:\/\/doi.org\/10.1186\/s40478-020-00934-5","journal-title":"Acta Neuropathol Commun"},{"key":"2929_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00401-025-02876-5","volume":"149","author":"RK Shahidehpour","year":"2025","unstructured":"Shahidehpour RK, Katsumata Y, Dickson DW, Ghayal NB, Aung KZ, Wu X et al (2025) LATE-NC stage 3: a diagnostic rubric to differentiate severe LATE-NC from FTLD-TDP. Acta Neuropathol 149:38.\u00a0https:\/\/doi.org\/10.1007\/s00401-025-02876-5","journal-title":"Acta Neuropathol"},{"key":"2929_CR48","doi-asserted-by":"publisher","unstructured":"Buciuc M, Martin PR, Tosakulwong N, Murray ME, Petrucelli L, Senjem ML et al (2022) TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration. NeuroImage Clin\u00a034:102954.\u00a0https:\/\/doi.org\/10.1016\/J.NICL.2022.102954","DOI":"10.1016\/J.NICL.2022.102954"},{"key":"2929_CR49","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ana.24388","volume":"77","author":"S Nag","year":"2015","unstructured":"Nag S, Yu L, Capuano AW, Wilson RS, Leurgans SE, Bennett DA et al (2015) Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer\u2019s disease. Ann Neurol 77:942\u2013952. https:\/\/doi.org\/10.1002\/ana.24388","journal-title":"Ann Neurol"},{"key":"2929_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01432-6","volume":"10","author":"MJ Koper","year":"2022","unstructured":"Koper MJ, Tom\u00e9 SO, Gawor K, Belet A, Van Schoor E, Schaeverbeke J et al (2022) LATE-NC aggravates GVD-mediated necroptosis in Alzheimer\u2019s disease. Acta Neuropathol Commun 10:128. https:\/\/doi.org\/10.1186\/s40478-022-01432-6","journal-title":"Acta Neuropathol Commun"},{"key":"2929_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-023-00653-0","volume":"18","author":"SO Tom\u00e9","year":"2023","unstructured":"Tom\u00e9 SO, Tsaka G, Ronisz A, Ospitalieri S, Gawor K, Gomes LA et al (2023) TDP-43 pathology is associated with increased tau burdens and seeding. Mol Neurodegener\u00a018:71.\u00a0https:\/\/doi.org\/10.1186\/s13024-023-00653-0","journal-title":"Mol Neurodegener"},{"key":"2929_CR52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-021-02295-2","volume":"141","author":"SO Tom\u00e9","year":"2021","unstructured":"Tom\u00e9 SO, Gomes L, Li X, Vandenberghe R, Tousseyn T, Thal DR (2021) TDP-43 interacts with pathological \u03c4 protein in Alzheimer\u2019s disease. Acta Neuropathol 141:795\u2013799. https:\/\/doi.org\/10.1007\/s00401-021-02295-2","journal-title":"Acta Neuropathol"},{"key":"2929_CR53","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1093\/nar\/gkx175","volume":"45","author":"J Gu","year":"2017","unstructured":"Gu J, Wu F, Xu W, Shi J, Hu W, Jin N et al (2017) TDP-43 suppresses tau expression via promoting its mRNA instability. Nucleic Acids Res 45:6177\u20136193. https:\/\/doi.org\/10.1093\/nar\/gkx175","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2929_CR54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2353\/AJPATH.2008.080003","volume":"173","author":"LM Igaz","year":"2008","unstructured":"Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M et al (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173:182. https:\/\/doi.org\/10.2353\/AJPATH.2008.080003","journal-title":"Am J Pathol"},{"key":"2929_CR55","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40478-019-0755-x","volume":"7","author":"KA Josephs","year":"2019","unstructured":"Josephs KA, Zhang Y-J, Baker M, Rademakers R, Petrucelli L, Dickson DW (2019) C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation. Acta Neuropathol Commun 7:100.\u00a0https:\/\/doi.org\/10.1186\/s40478-019-0755-x","journal-title":"Acta Neuropathol Commun"},{"key":"2929_CR56","doi-asserted-by":"publisher","unstructured":"Latimer CS, Stair JG, Hincks JC, Currey HN, Bird TD, Keene CD et al (2022) TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic C. elegans. Dis Model Mech 15:dmm049323.\u00a0https:\/\/doi.org\/10.1242\/DMM.049323","DOI":"10.1242\/DMM.049323"},{"key":"2929_CR57","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM et al (2014) TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease. Acta Neuropathol 127:811\u2013824. https:\/\/doi.org\/10.1007\/s00401-014-1269-z","journal-title":"Acta Neuropathol"},{"key":"2929_CR58","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/brain\/awab092","volume":"144","author":"PA Boyle","year":"2021","unstructured":"Boyle PA, Wang T, Yu L, Wilson RS, Dawe R, Arfanakis K et al (2021) To what degree is late life cognitive decline driven by age-related neuropathologies? Brain 144:2166\u20132175.\u00a0https:\/\/doi.org\/10.1093\/brain\/awab092","journal-title":"Brain"},{"key":"2929_CR59","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1001\/jamaneurol.2013.3961","volume":"70","author":"RS Wilson","year":"2013","unstructured":"Wilson RS, Yu L, Trojanowski JQ, Chen EY, Boyle PA, Bennett DA et al (2013) TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol 70:1418\u20131424. https:\/\/doi.org\/10.1001\/jamaneurol.2013.3961","journal-title":"JAMA Neurol"},{"key":"2929_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nbd.2017.04.012","volume":"103","author":"SA Davis","year":"2017","unstructured":"Davis SA, Ann Gan K, Dowell JA, Cairns NJ, Gitcho MA (2017) TDP-43 expression influences amyloid\u03b2 plaque deposition and tau aggregation. Neurobiol Dis 103:154\u2013162. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.012","journal-title":"Neurobiol Dis"},{"key":"2929_CR61","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s42003-023-05608-1","volume":"6","author":"S Dhakal","year":"2023","unstructured":"Dhakal S, Mondal M, Mirzazadeh A, Banerjee S, Ghosh A, Rangachari V (2023) \u03b1-Synuclein emulsifies TDP-43 prion-like domain\u2014RNA liquid droplets to promote heterotypic amyloid fibrils. Commun Biol 6:1227. https:\/\/doi.org\/10.1038\/s42003-023-05608-1","journal-title":"Commun Biol"},{"key":"2929_CR62","doi-asserted-by":"publisher","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Kubo M, Shimozawa A, Akiyama H et al (2014) Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun 2:88. https:\/\/doi.org\/10.1186\/s40478-014-0088-8","DOI":"10.1186\/s40478-014-0088-8"},{"key":"2929_CR63","doi-asserted-by":"crossref","unstructured":"Montalbano M, McAllen S, Lo CF, Sengupta U, Garcia S, Bhatt N et al (2020) TDP-43 and tau oligomers in Alzheimer\u2019s disease, amyotrophic lateral sclerosis, and frontotemporal dementia. Neurobiol Dis 146:105130","DOI":"10.1016\/j.nbd.2020.105130"},{"key":"2929_CR64","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41374-019-0196-y","volume":"99","author":"Y Chornenkyy","year":"2019","unstructured":"Chornenkyy Y, Fardo DW, Nelson PT (2019) Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy. Lab Invest 99:993\u20131007.\u00a0https:\/\/doi.org\/10.1038\/s41374-019-0196-y","journal-title":"Lab Invest"},{"key":"2929_CR65","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainresbull.2022.10.006","volume":"190","author":"DR Thal","year":"2022","unstructured":"Thal DR, Tome SO (2022) The central role of tau in Alzheimer \u2019 s disease\u202f: from neurofibrillary tangle maturation to the induction of cell death. Brain Res Bull 190:204\u2013217. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.10.006","journal-title":"Brain Res Bull"},{"key":"2929_CR66","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00401-017-1701-2","volume":"133","author":"M Sun","year":"2017","unstructured":"Sun M, Bell W, LaClair KD, Ling JP, Han H, Kageyama Y et al (2017) Cryptic exon incorporation occurs in Alzheimer\u2019s brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43. Acta Neuropathol 133:923\u2013931. https:\/\/doi.org\/10.1007\/s00401-017-1701-2","journal-title":"Acta Neuropathol"},{"key":"2929_CR67","doi-asserted-by":"publisher","unstructured":"Berning BA, Walker AK (2019) The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD. Front Neurosci 13:335. https:\/\/doi.org\/10.3389\/fnins.2019.00335","DOI":"10.3389\/fnins.2019.00335"},{"key":"2929_CR68","doi-asserted-by":"publisher","first-page":"9049","DOI":"10.1074\/jbc.M112.438564","volume":"288","author":"Y-TT Wang","year":"2013","unstructured":"Wang Y-TT, Kuo P-HH, Chiang C-HH, Liang J-RR, Chen Y-RR, Wang S et al (2013) The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates. J Biol Chem 288:9049\u20139057. https:\/\/doi.org\/10.1074\/jbc.M112.438564","journal-title":"J Biol Chem"},{"key":"2929_CR69","doi-asserted-by":"publisher","first-page":"13302","DOI":"10.1074\/jbc.M800342200","volume":"283","author":"MJ Winton","year":"2008","unstructured":"Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VMY (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem 283:13302\u201313309. https:\/\/doi.org\/10.1074\/jbc.M800342200","journal-title":"J Biol Chem"},{"key":"2929_CR70","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.febslet.2015.06.009","volume":"589","author":"M-X Che","year":"2015","unstructured":"Che M-X, Jiang L-L, Li H-Y, Jiang Y-J, Hu H-Y (2015) TDP-35 sequesters TDP-43 into cytoplasmic inclusions through binding with RNA. FEBS Lett 589:1920\u20131928.\u00a0https:\/\/doi.org\/10.1016\/j.febslet.2015.06.009","journal-title":"FEBS Lett"},{"key":"2929_CR71","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-020-02211-0","volume":"140","author":"Y Katsumata","year":"2020","unstructured":"Katsumata Y, Abner EL, Karanth S, Teylan MA, Mock CN, Cykowski MD et al (2020) Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy. Acta Neuropathol 140:659\u2013674. https:\/\/doi.org\/10.1007\/s00401-020-02211-0","journal-title":"Acta Neuropathol"},{"key":"2929_CR72","doi-asserted-by":"publisher","first-page":"193.e17","DOI":"10.1016\/j.neurobiolaging.2017.01.003","volume":"53","author":"Y Katsumata","year":"2017","unstructured":"Katsumata Y, Nelson PT, Ellingson SR, Fardo DW (2017) Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging 53:193.e17-193.e25. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.01.003","journal-title":"Neurobiol Aging"},{"key":"2929_CR73","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1093\/brain\/awab437","volume":"145","author":"C Pottier","year":"2022","unstructured":"Pottier C, Mateiu L, Baker MC, Dejesus-Hernandez M, Teixeira Vicente C, Finch NA et al (2022) Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations. Brain 145:2472\u20132485. https:\/\/doi.org\/10.1093\/brain\/awab437","journal-title":"Brain"},{"key":"2929_CR74","doi-asserted-by":"publisher","first-page":"fcae442","DOI":"10.1093\/braincomms\/fcae442","volume":"6","author":"K Gawor","year":"2024","unstructured":"Gawor K, Tom\u00e9 SO, Vandenberghe R, Van Damme P, Vandenbulcke M, Otto M et al (2024) Amygdala-predominant \u03b1-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer\u2019s disease. Brain Commun 6:fcae442. https:\/\/doi.org\/10.1093\/braincomms\/fcae442","journal-title":"Brain Commun"},{"key":"2929_CR75","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40478-021-01250-2","volume":"9","author":"AJ Dugan","year":"2021","unstructured":"Dugan AJ, Nelson PT, Katsumata Y, Shade LM, Boehme KL, Teylan MA et al (2021) Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol Commun 9:152. https:\/\/doi.org\/10.1186\/s40478-021-01250-2","journal-title":"Acta Neuropathol Commun"},{"key":"2929_CR76","doi-asserted-by":"publisher","first-page":"106412","DOI":"10.1016\/j.nbd.2024.106412","volume":"191","author":"Y Katsumata","year":"2024","unstructured":"Katsumata Y, Wu X, Aung KZ, Gauthreaux K, Mock C, Forrest SL et al (2024) Pathologic correlates of aging-related tau astrogliopathy: ARTAG is associated with LATE-NC and cerebrovascular pathologies, but not with ADNC. Neurobiol Dis 191:106412.\u00a0https:\/\/doi.org\/10.1016\/j.nbd.2024.106412","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2929_CR77","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ et al (2020) Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun 11:667.\u00a0https:\/\/doi.org\/10.1038\/s41467-019-14279-8","journal-title":"Nat Commun"},{"key":"2929_CR78","doi-asserted-by":"publisher","first-page":"e62199","DOI":"10.7554\/eLife.62199","volume":"9","author":"M Shinohara","year":"2020","unstructured":"Shinohara M, Kanekiyo T, Tachibana M, Kurti A, Shinohara M, Fu Y et al (2020) Apoe2 is associated with longevity independent of Alzheimer\u2019s disease. Elife 9:e62199. https:\/\/doi.org\/10.7554\/eLife.62199","journal-title":"Elife"},{"key":"2929_CR79","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ana.26580","volume":"93","author":"AD Meneses","year":"2023","unstructured":"Meneses AD, Koga S, Li Z, O\u2019Leary J, Li F, Chen K et al (2023) APOE2 exacerbates TDP-43 related toxicity in the absence of Alzheimer pathology. Ann Neurol 93:830\u2013843. https:\/\/doi.org\/10.1002\/ana.26580","journal-title":"Ann Neurol"},{"key":"2929_CR80","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.ejhg.5200820","volume":"10","author":"P Verpillat","year":"2002","unstructured":"Verpillat P, Camuzat A, Hannequin D, Thomas-Anterion C, Puel M, Belliard S et al (2002) Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. Eur J Hum Genet 10:399\u2013405. https:\/\/doi.org\/10.1038\/sj.ejhg.5200820","journal-title":"Eur J Hum Genet"},{"key":"2929_CR81","doi-asserted-by":"publisher","first-page":"eadf5128","DOI":"10.1126\/scitranslmed.adf5128","volume":"16","author":"MJ Koper","year":"2024","unstructured":"Koper MJ, Moonen S, Ronisz A, Ospitalieri S, Callaerts-Vegh Z, T'Syen D et al (2024) Inhibition of GVD-necroptosis rescues neuronal death in a mouse model of Alzheimer\u2019s pathology. Sci Transl Med 16:eadf5128.\u00a0https:\/\/doi.org\/10.1126\/scitranslmed.adf5128","journal-title":"Sci Transl Med"},{"key":"2929_CR82","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00401-019-02046-4","volume":"138","author":"VI Wiersma","year":"2019","unstructured":"Wiersma VI, van Ziel AM, Vazquez-Sanchez S, N\u00f6lle A, Berenjeno-Correa E, Bonaterra-Pastra A et al (2019) Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology. Acta Neuropathol 138:943\u2013970. https:\/\/doi.org\/10.1007\/s00401-019-02046-4","journal-title":"Acta Neuropathol"},{"key":"2929_CR83","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/nan.12668","volume":"47","author":"E Van Schoor","year":"2020","unstructured":"Van Schoor E, Koper MJ, Ospitalieri S, Dedeene L, Tom\u00e9 SO, Vandenberghe R et al (2020) Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS\/FTLD cases. Neuropathol Appl Neurobiol  47:328\u2013345. https:\/\/doi.org\/10.1111\/nan.12668","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2929_CR84","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-024-02789-9","volume":"148","author":"AE Denning","year":"2024","unstructured":"Denning AE, Ittyerah R, Levorse LM, Sadeghpour N, Athalye C, Chung E et al (2024) Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer\u2019s disease continuum. Acta Neuropathol 148:37.\u00a0https:\/\/doi.org\/10.1007\/s00401-024-02789-9","journal-title":"Acta Neuropathol"},{"key":"2929_CR85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40478-018-0531-3","volume":"6","author":"S Nag","year":"2018","unstructured":"Nag S, Yu L, Boyle PA, Leurgans SE, Bennett DA, Schneider JA (2018) TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer\u2019s disease. Acta Neuropathol Commun 6:33.\u00a0https:\/\/doi.org\/10.1186\/s40478-018-0531-3","journal-title":"Acta Neuropathol Commun"},{"key":"2929_CR86","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H et al (2008) Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe consortium. Brain Pathol 18:484\u2013496. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00147.x","journal-title":"Brain Pathol"},{"key":"2929_CR87","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/S00401-023-02606-9","volume":"146","author":"L Sordo","year":"2023","unstructured":"Sordo L, Qian T, Bukhari SA, Nguyen KM, Woodworth DC, Head E et al (2023) Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old. Acta Neuropathol 146:415\u2013432.\u00a0https:\/\/doi.org\/10.1007\/S00401-023-02606-9","journal-title":"Acta Neuropathol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02929-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02929-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02929-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:03:11Z","timestamp":1757955791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02929-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2929"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02929-9","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DRT & SOT received consultant honorary from Muna Therapeutics (Belgium). DRT collaborated with Novartis Pharma AG (Switzerland) and GE-Healthcare (UK). RV\u2019s institution has clinical trial agreements (RV as PI) with Alector, AviadoBio, Biogen, Bristol Myers Squibb, Eli Lilly, Johnson & Johnson, and UCB. RV\u2019s institution has consultancy agreements (RV as DSMB or DMC member) with AC Immune and Novartis. KS, PTN and DRT are members of the editorial board of Acta Neuropathologica. CAFvA received honoraria from serving on the scientific advisory board of Biogen, Roche, Novo Nordisk, Biontech, Lilly, Dr. Willmar Schwabe GmbH &Co. KG, RoX Health GmbH, and MindAhead UG, and has received funding for travel and speaker honoraria from Lilly, Novo Nordisk, Roche, Novartis, Medical Tribune Verlagsgesellschaft mbH, Landesvereinigung f\u00fcr Gesundheit und Akademie f\u00fcr Sozialmedizin Niedersachsen e. V., FomF GmbH | Forum f\u00fcr medizinische Fortbildung, and Dr. Willmar Schwabe GmbH &Co. KG. MO received consultant honorary from Biogen, Axon Neuroscience, Fujirebio, and Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"28"}}